Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia

被引：0
|
作者：
Takahiro Kambara
Rei Shibata
Yuusuke Sakamoto
Teruhiro Sakaguchi
Hiroyuki Osanai
Yoshihito Nakashima
Hiroshi Asano
Toyoaki Murohara
Masayoshi Ajioka
机构：
[1] Tosei General Hospital,Department of Cardiovascular Medicine
[2] Nagoya University Graduate School of Medicine,Department of Advanced Cardiovascular Therapeutics
[3] Nagoya University Graduate School of Medicine,Department of Cardiology
来源：
BMC Research Notes | / 17卷
关键词：
Heart failure; HIF-PH inhibitor; NT-proBNP; Renal anemia; Ferritin; TSAT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
    Kambara, Takahiro
    Shibata, Rei
    Sakamoto, Yuusuke
    Sakaguchi, Teruhiro
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    BMC RESEARCH NOTES, 2024, 17 (01)
  • [2] HIF prolyl hydroxylase inhibitors for anemia
    Muchnik, Eugene
    Kaplan, Joshua
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (05) : 645 - 656
  • [3] Initial experience of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with heart failure and renal anemia
    Nakamura, Makiko
    Imamura, Teruhiko
    Sobajima, Mitsuo
    Kinugawa, Koichiro
    HEART AND VESSELS, 2023, 38 (02) : 284 - 290
  • [4] Initial experience of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with heart failure and renal anemia
    Makiko Nakamura
    Teruhiko Imamura
    Mitsuo Sobajima
    Koichiro Kinugawa
    Heart and Vessels, 2023, 38 (2) : 284 - 290
  • [5] HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
    Patrick H. Maxwell
    Kai-Uwe Eckardt
    Nature Reviews Nephrology, 2016, 12 : 157 - 168
  • [6] HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
    Maxwell, Patrick H.
    Eckardt, Kai-Uwe
    NATURE REVIEWS NEPHROLOGY, 2016, 12 (03) : 157 - 168
  • [7] HIF-Prolyl Hydroxylase-Inhibitors - An interesting Alternative for Treating renal Anemia with Erythropoietin Analogues?
    Lutz, J.
    NEPHROLOGE, 2016, 11 (02): : 146 - 147
  • [8] HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
    Wyatt, Christina M.
    Drueke, Tilman B.
    KIDNEY INTERNATIONAL, 2016, 90 (05) : 923 - 925
  • [9] Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia
    Kurata, Yu
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [10] Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia
    Ogoshi, Yosuke
    Matsui, Takuya
    Mitani, Ikuo
    Yokota, Masahiro
    Terashita, Masakazu
    Motoda, Dai
    Ueyama, Kazuhito
    Hotta, Takahiro
    Ito, Takashi
    Hase, Yasunori
    Fukui, Kenji
    Deai, Katsuya
    Yoshiuchi, Hiromi
    Ito, Soichiro
    Abe, Hiroyuki
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (12): : 1320 - 1325
12345